Infarct size and distribution in non-infarct artery territory in the randomised PRAMI trial participants (n = 80) in Glasgow
| Infarct-only PCI n = 39 (49%) | Multivessel PCI n = 41 (51%) | P | |
|---|---|---|---|
| 1 week post-MI | |||
| Infarct size,% LV‘ | 16.9 (14.0) | 13.9 (12.1) | 0.32 |
| Infarct in non-IRA territory, n (%) | 0 (0) | 0 (0) | 1.00 |
| 1 year post-MI | |||
| Infarct size, % LV | 13.9 (10.1) | 11.1 (11.2) | 0.20 |
| Change in infarct size from baseline,% LV mass* | -2.23 (-9.97, 0.56) | -1.73 (-7.10, 0.94) | 0.60 |
| Infarct in non-IRA territory, n (%) | 2 (5.1) | 3 (7.3) | 1.00 |